KindlyMD, Inc. (NASDAQ:NAKA – Get Free Report) has been assigned a consensus rating of “Hold” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $30.00.
Several research firms have recently issued reports on NAKA. TD Cowen assumed coverage on KindlyMD in a research report on Friday, April 10th. They set a “buy” rating and a $40.00 price objective for the company. Weiss Ratings raised KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Wall Street Zen upgraded KindlyMD to a “sell” rating in a research note on Saturday, May 23rd. Finally, Maxim Group lowered their price target on KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a report on Monday, April 6th.
Check Out Our Latest Stock Analysis on KindlyMD
Insider Buying and Selling at KindlyMD
Institutional Investors Weigh In On KindlyMD
Several hedge funds and other institutional investors have recently bought and sold shares of NAKA. Geode Capital Management LLC raised its stake in KindlyMD by 76.2% during the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after acquiring an additional 8,386 shares in the last quarter. Osaic Holdings Inc. purchased a new position in shares of KindlyMD during the second quarter worth about $215,000. Victory Capital Management Inc. acquired a new stake in shares of KindlyMD during the third quarter worth about $1,007,000. UBS Group AG lifted its holdings in shares of KindlyMD by 5,244.3% in the 3rd quarter. UBS Group AG now owns 387,142 shares of the company’s stock valued at $9,655,000 after purchasing an additional 379,898 shares during the last quarter. Finally, Quadrature Capital Ltd acquired a new stake in shares of KindlyMD in the 3rd quarter valued at about $5,460,000.
KindlyMD Trading Up 2.1%
Shares of NAKA stock opened at $4.97 on Friday. The firm has a fifty day moving average price of $4.74 and a 200 day moving average price of $8.97. The company has a market cap of $86.48 million, a P/E ratio of -0.12 and a beta of 16.05. KindlyMD has a 12 month low of $3.33 and a 12 month high of $659.20.
KindlyMD (NASDAQ:NAKA – Get Free Report) last posted its earnings results on Wednesday, May 13th. The company reported ($0.38) EPS for the quarter. KindlyMD had a negative net margin of 7,397.12% and a negative return on equity of 81.32%. The business had revenue of $2.68 million during the quarter. On average, equities analysts forecast that KindlyMD will post -16.8 EPS for the current year.
KindlyMD Company Profile
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.
Featured Stories
- Five stocks we like better than KindlyMD
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
